Why do I have small yellow bumps on my skin?

Small yellow bumps on skin are often cholesterol deposits called xanthomas, indicating high cholesterol or lipid disorders. While some causes like milia are harmless, xanthomas require medical evaluation and cholesterol testing to prevent cardiovascular complications.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Yellow Bumps on Your Skin

Finding small yellow bumps on your skin can be concerning, especially when they appear suddenly or persist despite your skincare routine. These bumps can range from tiny, barely noticeable spots to larger, more prominent patches that affect your appearance and confidence. While some yellow bumps are harmless and purely cosmetic, others can signal underlying health conditions that require medical attention.

The most common culprits behind yellow skin bumps include cholesterol deposits (xanthomas), blocked oil glands (milia), and sebaceous hyperplasia. Each condition has distinct characteristics, causes, and treatment approaches. Understanding what's causing your yellow bumps is the first step toward appropriate treatment and, potentially, addressing underlying health issues.

Xanthomas: When Cholesterol Shows Up on Your Skin

Xanthomas are yellowish deposits of fat that build up under your skin, most commonly appearing around the eyes, joints, hands, feet, and buttocks. These bumps develop when excess lipids, particularly cholesterol and triglycerides, accumulate in your skin cells. They're not just a cosmetic concern—xanthomas often indicate abnormal blood lipid levels that could increase your risk of heart disease.

Types of Xanthomas and Their Characteristics

Different xanthoma types indicate specific lipid abnormalities and require targeted treatment approaches.
TypeCommon LocationsAppearanceAssociated Lipid Disorder
XanthelasmaXanthelasmaEyelidsFlat, soft yellow patchesMixed hyperlipidemia
TuberousTuberousElbows, knees, buttocksFirm, painless nodulesHigh triglycerides
TendinousTendinousAchilles tendon, handsHard lumps on tendonsFamilial hypercholesterolemia
EruptiveEruptiveButtocks, shoulders, armsSmall yellow-red clustersVery high triglycerides (>1000 mg/dL)
PlanePlanePalms, skin foldsFlat orange-yellow patchesBiliary cirrhosis, myeloma

Different xanthoma types indicate specific lipid abnormalities and require targeted treatment approaches.

Research published in the Journal of Clinical Lipidology shows that approximately 50% of people with xanthomas have underlying lipid disorders. The bumps themselves are painless and don't pose direct health risks, but they serve as visible warning signs of potential cardiovascular problems. If you notice these yellow deposits, comprehensive cholesterol testing can reveal whether you have elevated lipid levels that need management.

Types of Xanthomas and Their Locations

Different types of xanthomas appear in specific body areas and can indicate various lipid abnormalities. Understanding these distinctions helps with proper diagnosis and treatment planning.

  • Xanthelasma palpebrarum: Flat, yellow patches on eyelids, the most common type
  • Tuberous xanthomas: Firm, painless nodules on elbows, knees, and buttocks
  • Tendinous xanthomas: Hard lumps attached to tendons, especially Achilles tendon
  • Eruptive xanthomas: Small yellow-red bumps that appear suddenly in clusters
  • Plane xanthomas: Flat patches in skin folds and creases

Risk Factors and Associated Conditions

Several factors increase your likelihood of developing xanthomas. Genetic conditions like familial hypercholesterolemia cause extremely high cholesterol levels from birth, leading to early xanthoma formation. Other risk factors include diabetes, hypothyroidism, liver disease, and certain medications like corticosteroids or retinoids.

A study in the Archives of Dermatology found that patients with xanthelasma had a 48% higher risk of heart attack and a 39% higher risk of ischemic heart disease compared to those without these lesions. This correlation underscores the importance of treating xanthomas as potential markers for cardiovascular risk rather than mere cosmetic issues.

Other Common Causes of Yellow Skin Bumps

Milia: Tiny Keratin Cysts

Milia are small, white to yellowish bumps that commonly appear on the face, particularly around the eyes and cheeks. These tiny cysts form when keratin becomes trapped beneath the skin's surface. Unlike xanthomas, milia aren't related to cholesterol levels and don't indicate systemic health issues. They're especially common in newborns but can affect people of all ages.

Primary milia occur spontaneously, while secondary milia develop after skin damage from burns, blistering, or excessive sun exposure. While harmless, persistent milia in adults might warrant evaluation to rule out underlying skin conditions or review skincare routines that might be contributing to their formation.

Sebaceous Hyperplasia

Sebaceous hyperplasia presents as small, yellowish bumps with a central indentation, typically appearing on the forehead, nose, and cheeks. These bumps result from enlarged oil glands and become more common with age, affecting up to 1% of healthy adults. While benign, they can be mistaken for basal cell carcinoma, making proper diagnosis important.

Factors contributing to sebaceous hyperplasia include sun damage, genetic predisposition, and immunosuppression. Treatment options range from topical retinoids to laser therapy, though recurrence is common regardless of the treatment method chosen.

When Yellow Bumps Signal Health Problems

While not all yellow bumps indicate serious health issues, certain characteristics should prompt medical evaluation. Sudden appearance of multiple bumps, rapid growth, associated symptoms like itching or pain, or bumps accompanied by other systemic symptoms warrant professional assessment. These could indicate underlying metabolic disorders, liver dysfunction, or lipid abnormalities requiring treatment.

The connection between skin manifestations and internal health is well-documented. A comprehensive metabolic panel, including detailed lipid testing, can uncover hidden health issues manifesting as skin changes. Regular monitoring of biomarkers like cholesterol, triglycerides, and inflammatory markers helps track treatment effectiveness and prevent complications.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnosis and Medical Evaluation

Proper diagnosis of yellow skin bumps typically begins with a visual examination by a dermatologist or primary care physician. They'll assess the bumps' appearance, location, and distribution pattern. In some cases, a skin biopsy might be necessary to confirm the diagnosis, especially when distinguishing between similar-looking conditions.

Blood tests play a crucial role in diagnosis, particularly when xanthomas are suspected. A complete lipid panel measuring total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and advanced markers like ApoB can reveal underlying lipid disorders. Additional tests might include thyroid function tests, liver enzymes, and glucose levels to identify contributing conditions.

Treatment Options for Yellow Skin Bumps

Medical Treatments

Treatment approaches vary depending on the underlying cause. For xanthomas caused by high cholesterol, addressing the lipid disorder is paramount. Statins and other lipid-lowering medications can reduce cholesterol levels and potentially shrink existing xanthomas while preventing new ones from forming. However, medication alone might not eliminate existing bumps completely.

Cosmetic removal options include cryotherapy (freezing), laser treatment, surgical excision, chemical peels with trichloroacetic acid, and electrodesiccation. Success rates vary, and recurrence is possible, especially if underlying lipid abnormalities aren't addressed. A study in Dermatologic Surgery reported that laser treatment had a 93% success rate for xanthelasma removal, though 40% of patients experienced recurrence within one year.

Lifestyle Modifications

Lifestyle changes form the foundation of managing conditions that cause yellow skin bumps, particularly when high cholesterol is involved. Dietary modifications can significantly impact lipid levels and overall skin health.

  • Reduce saturated fat intake to less than 7% of total calories
  • Increase soluble fiber consumption to 10-25 grams daily
  • Add plant sterols and stanols (2 grams daily) through fortified foods
  • Include omega-3 fatty acids from fish or supplements
  • Maintain a healthy weight through portion control and regular exercise
  • Limit alcohol consumption and avoid smoking

Regular physical activity improves lipid profiles and overall cardiovascular health. The American Heart Association recommends at least 150 minutes of moderate-intensity aerobic exercise weekly, plus muscle-strengthening activities twice per week. These lifestyle modifications not only help manage existing conditions but also prevent future complications.

Prevention Strategies

Preventing yellow skin bumps involves maintaining optimal metabolic health and protecting your skin. Regular health screenings can detect lipid abnormalities before they manifest as skin symptoms. The National Cholesterol Education Program recommends lipid screening every 4-6 years for adults, though more frequent testing may be necessary for those with risk factors.

Sun protection plays a crucial role in preventing certain types of yellow bumps, particularly sebaceous hyperplasia and some forms of milia. Daily use of broad-spectrum sunscreen with at least SPF 30, protective clothing, and avoiding peak sun hours can minimize sun damage that contributes to these conditions.

For those with genetic predispositions to high cholesterol or family histories of xanthomas, early intervention is key. Starting preventive measures in young adulthood, including regular lipid monitoring and lifestyle optimization, can prevent or delay the development of both skin manifestations and cardiovascular complications.

Monitoring Your Progress

Tracking the effectiveness of treatment requires regular monitoring of both skin changes and underlying biomarkers. Photograph your skin bumps monthly to document changes in size, color, or number. This visual record helps healthcare providers assess treatment response and adjust strategies as needed.

Blood biomarker testing should occur at intervals determined by your initial results and treatment plan. For those on lipid-lowering medications, testing every 6-12 weeks initially helps establish the right dosage, followed by monitoring every 3-6 months once stable. Advanced lipid testing that includes particle size and inflammatory markers provides deeper insights into cardiovascular risk beyond standard cholesterol measurements.

If you're interested in understanding your complete lipid profile and metabolic health markers, comprehensive at-home testing makes regular monitoring convenient and accessible. Tracking these biomarkers over time helps you and your healthcare provider make informed decisions about treatment adjustments and lifestyle modifications. For a free analysis of your existing blood test results, you can use SiPhox Health's upload service to get personalized insights and recommendations based on your unique health data.

Taking Action for Your Skin and Overall Health

Small yellow bumps on your skin might seem like a minor cosmetic concern, but they can provide valuable insights into your overall health. Whether they're harmless milia or cholesterol-laden xanthomas signaling cardiovascular risk, proper evaluation and treatment are essential. Don't ignore these visible signs your body is providing about your internal health.

Work with healthcare providers to develop a comprehensive treatment plan addressing both the skin manifestations and any underlying conditions. Remember that successful management often requires patience—skin changes typically lag behind improvements in blood biomarkers by several months. Stay consistent with treatment, maintain healthy lifestyle habits, and monitor your progress regularly.

Your skin often reflects your internal health, making those yellow bumps potential early warning signs worth investigating. By taking action now, you can address cosmetic concerns while potentially preventing more serious health complications down the road. Regular health monitoring, appropriate medical treatment, and lifestyle optimization work together to improve both your skin appearance and overall wellbeing.

References

  1. Zak, A., Zeman, M., Slaby, A., & Vecka, M. (2014). Xanthomas: Clinical and pathophysiological relations. Biomedical Papers, 158(2), 181-188.[PubMed][DOI]
  2. Christoffersen, M., Frikke-Schmidt, R., Schnohr, P., Jensen, G. B., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2011). Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. Archives of Dermatology, 147(10), 1217-1224.[PubMed][DOI]
  3. Nair, P. A., & Singhal, R. (2017). Xanthomas: A review of the literature. Indian Dermatology Online Journal, 8(6), 426-431.[PubMed][DOI]
  4. Bergman, R. (1994). The pathogenesis and clinical significance of xanthelasma palpebrarum. Journal of the American Academy of Dermatology, 30(2), 236-242.[PubMed][DOI]
  5. Jellinek, N. J., & Sima, A. (2020). Sebaceous hyperplasia: A review and update on treatment modalities. Journal of Clinical and Aesthetic Dermatology, 13(8), 15-21.[PubMed]
  6. Parker, F. (1985). Xanthomas and hyperlipidemias. Journal of the American Academy of Dermatology, 13(1), 1-30.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cholesterol at home?

You can test your cholesterol at home with SiPhox Health's Apob Advanced Cholesterol Panel. This CLIA-certified test includes comprehensive lipid markers including ApoA, ApoB, LDL-C, HDL-C, total cholesterol, and triglycerides, providing lab-quality results from the comfort of your home.

Are yellow bumps on skin always related to high cholesterol?

No, not all yellow bumps indicate high cholesterol. While xanthomas are cholesterol deposits, other causes include milia (keratin cysts), sebaceous hyperplasia (enlarged oil glands), and various benign skin conditions. Proper medical evaluation can determine the exact cause.

Can xanthomas go away on their own?

Xanthomas rarely disappear without treatment. While managing underlying cholesterol levels through medication and lifestyle changes can prevent new ones and potentially shrink existing bumps, cosmetic removal procedures are often needed to eliminate them completely.

What cholesterol level causes xanthomas?

Xanthomas typically develop when total cholesterol exceeds 300 mg/dL or triglycerides exceed 500 mg/dL, though they can occur at lower levels in people with genetic lipid disorders. Some individuals with familial hypercholesterolemia develop xanthomas even with moderately elevated cholesterol.

Should I be worried about small yellow bumps around my eyes?

Yellow bumps around the eyes (xanthelasma) should be evaluated by a healthcare provider as they're associated with increased cardiovascular risk. Studies show people with xanthelasma have a 48% higher risk of heart attack, making cholesterol testing and cardiovascular assessment important.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details